Literature DB >> 24999301

Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder?

Jennifer M Park1, Brent J Small2, Daniel A Geller3, Tanya K Murphy4, Adam B Lewin4, Eric A Storch4.   

Abstract

Clinical studies in adults and children with obsessive-compulsive disorder (OCD) have shown that d-cycloserine (DCS) can improve treatment response by enhancing fear extinction learning during exposure-based psychotherapy. Some have hypothesized that improved treatment response is a function of increased compliance and engagement in therapeutic homework tasks, a core component of behavioral treatment. The present study examined the relationship between DCS augmented cognitive-behavioral therapy (CBT) and homework compliance in a double-blind, placebo controlled trial with 30 youth with OCD. All children received 10 CBT sessions, the last seven of which included exposure and response prevention paired with DCS or placebo dosed 1 h before the session started. Results suggested that DCS augmented CBT did not predict improved homework compliance over the course of treatment, relative to the placebo augmented CBT group. However, when groups were collapsed, homework compliance was directly associated with treatment outcome. These findings suggest that while DCS may not increase homework compliance over time, more generally, homework compliance is an integral part of pediatric OCD treatment outcome.

Entities:  

Keywords:  Children; Exposure and response prevention; Homework compliance; Obsessive–compulsive disorder; d-Cycloserine

Year:  2014        PMID: 24999301      PMCID: PMC4078886          DOI: 10.1007/s10826-013-9742-1

Source DB:  PubMed          Journal:  J Child Fam Stud        ISSN: 1062-1024


  50 in total

1.  Expectancy/Credibility Change as a Mediator of Cognitive Behavioral Therapy for Generalized Anxiety Disorder: Mechanism of Action or Proxy for Symptom Change?

Authors:  Michelle G Newman; Aaron J Fisher
Journal:  Int J Cogn Ther       Date:  2010-09

Review 2.  Obsessive-compulsive disorder in children and adolescents: a review.

Authors:  D A Geller; J Biederman; J Jones; S Shapiro; S Schwartz; K S Park
Journal:  Harv Rev Psychiatry       Date:  1998 Jan-Feb       Impact factor: 3.732

3.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

4.  Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.

Authors:  Eric A Storch; Tanya K Murphy; Gary R Geffken; Ohel Soto; Muhammad Sajid; Pam Allen; Jonathan W Roberti; Erin M Killiany; Wayne K Goodman
Journal:  Psychiatry Res       Date:  2004-11-30       Impact factor: 3.222

5.  Treatment compliance and outcome in obsessive-compulsive disorder.

Authors:  Jonathan S Abramowitz; Martin E Franklin; Lori A Zoellner; Corrie L DiBernardo
Journal:  Behav Modif       Date:  2002-09

6.  Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention.

Authors:  D Quartermain; J Mower; M F Rafferty; R L Herting; T H Lanthorn
Journal:  Eur J Pharmacol       Date:  1994-05-12       Impact factor: 4.432

7.  Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.

Authors:  Hunna J Watson; Clare S Rees
Journal:  J Child Psychol Psychiatry       Date:  2008-05       Impact factor: 8.982

8.  D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.

Authors:  Eric A Storch; Lisa J Merlo; Michael Bengtson; Tanya K Murphy; Mark H Lewis; Mark C Yang; Marni L Jacob; Michael Larson; Adam Hirsh; Melanie Fernandez; Gary R Geffken; Wayne K Goodman
Journal:  Int Clin Psychopharmacol       Date:  2007-07       Impact factor: 1.659

9.  Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches.

Authors:  Eric A Storch; Gary R Geffken; Lisa J Merlo; Giselle Mann; Danny Duke; Melissa Munson; Jennifer Adkins; Kristen M Grabill; Tanya K Murphy; Wayne K Goodman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-04       Impact factor: 8.829

View more
  8 in total

Review 1.  Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.

Authors:  Joseph F McGuire; Adam B Lewin; Eric A Storch
Journal:  Expert Rev Neurother       Date:  2014-06-27       Impact factor: 4.618

2.  Bothersome tics in patients with chronic tic disorders: Characteristics and individualized treatment response to behavior therapy.

Authors:  Joseph F McGuire; John Piacentini; Lawrence Scahill; Douglas W Woods; Robert Villarreal; Sabine Wilhelm; John T Walkup; Alan L Peterson
Journal:  Behav Res Ther       Date:  2015-05-12

Review 3.  Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.

Authors:  Rasmita Ori; Taryn Amos; Hanna Bergman; Karla Soares-Weiser; Jonathan C Ipser; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2015-05-10

4.  Homework adherence predicts therapeutic improvement from behavior therapy in Tourette's disorder.

Authors:  Joey K-Y Essoe; Emily J Ricketts; Kesley A Ramsey; John Piacentini; Douglas W Woods; Alan L Peterson; Lawrence Scahill; Sabine Wilhelm; John T Walkup; Joseph F McGuire
Journal:  Behav Res Ther       Date:  2021-03-13

Review 5.  Optimising Exposure for Children and Adolescents with Anxiety, OCD and PTSD: A Systematic Review.

Authors:  Hannah Plaisted; Polly Waite; Kate Gordon; Cathy Creswell
Journal:  Clin Child Fam Psychol Rev       Date:  2021-02-06

6.  Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: a study of feasibility and preliminary efficacy.

Authors:  Johanne Jeppesen Lomholt; Mikael Thastum; Anne Estmann Christensen; Anne Leegaard; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2015-08-21       Impact factor: 3.054

Review 7.  Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Authors:  Zoya Marinova; De-Maw Chuang; Naomi Fineberg
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time.

Authors:  Georgios D Kotzalidis; Antonio Del Casale; Maurizio Simmaco; Lucia Pancheri; Roberto Brugnoli; Marco Paolini; Ida Gualtieri; Stefano Ferracuti; Valeria Savoja; Ilaria Cuomo; Lavinia De Chiara; Alessio Mosca; Gabriele Sani; Paolo Girardi; Maurizio Pompili; Chiara Rapinesi
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.